Patents/Assignees

Cyteir Therapeutics, Inc.

3 patents in portfolio

US12064419utility2024
Methods of Using RAD51 Inhibitors for Treatment of Pancreatic Cancer
0 cites
US11932636utility2024
RAD51 Inhibitors
0 cites
US11607404utility2023
Combinations of RAD51 and PARP Inhibitors
0 cites